These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 7579052

  • 1. Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study Group.
    Klahr S, Breyer JA, Beck GJ, Dennis VW, Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME.
    J Am Soc Nephrol; 1995 Jun; 5(12):2037-47. PubMed ID: 7579052
    [Abstract] [Full Text] [Related]

  • 2. Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine concentration in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Apr; 7(4):556-66. PubMed ID: 8724889
    [Abstract] [Full Text] [Related]

  • 3. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study.
    Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, Kusek JW, Rogers NL, Teschan PE.
    Am J Kidney Dis; 1996 May; 27(5):652-63. PubMed ID: 8629624
    [Abstract] [Full Text] [Related]

  • 4. Effects of dietary protein restriction on the progression of moderate renal disease in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Dec; 7(12):2616-26. PubMed ID: 8989740
    [Abstract] [Full Text] [Related]

  • 5. Short-term effects of protein intake, blood pressure, and antihypertensive therapy on glomerular filtration rate in the Modification of Diet in Renal Disease Study.
    J Am Soc Nephrol; 1996 Oct; 7(10):2097-109. PubMed ID: 8915969
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure in early autosomal dominant polycystic kidney disease.
    Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB, HALT-PKD Trial Investigators.
    N Engl J Med; 2014 Dec 11; 371(24):2255-66. PubMed ID: 25399733
    [Abstract] [Full Text] [Related]

  • 7. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
    Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MF.
    Kidney Int; 2017 Feb 11; 91(2):493-500. PubMed ID: 27993381
    [Abstract] [Full Text] [Related]

  • 8. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW.
    Am J Kidney Dis; 2000 Mar 11; 35(3):427-32. PubMed ID: 10692268
    [Abstract] [Full Text] [Related]

  • 9. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 11; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 10. Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.
    Choukroun G, Itakura Y, Albouze G, Christophe JL, Man NK, Grünfeld JP, Jungers P.
    J Am Soc Nephrol; 1995 Dec 11; 6(6):1634-42. PubMed ID: 8749691
    [Abstract] [Full Text] [Related]

  • 11. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G.
    Kidney Int; 1998 May 11; 53(5):1209-16. PubMed ID: 9573535
    [Abstract] [Full Text] [Related]

  • 12. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S.
    Kidney Int; 1999 Dec 11; 56(6):2181-90. PubMed ID: 10594794
    [Abstract] [Full Text] [Related]

  • 13. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
    Clin J Am Soc Nephrol; 2007 Jan 11; 2(1):112-20. PubMed ID: 17699395
    [Abstract] [Full Text] [Related]

  • 14. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 17. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.
    Hebert LA, Kusek JW, Greene T, Agodoa LY, Jones CA, Levey AS, Breyer JA, Faubert P, Rolin HA, Wang SR.
    Hypertension; 1997 Sep 25; 30(3 Pt 1):428-35. PubMed ID: 9314428
    [Abstract] [Full Text] [Related]

  • 18. Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making.
    Miquel-Rodríguez R, González-Toledo B, Pérez-Gómez MV, Cobo-Caso MÁ, Delgado-Mallén P, Estupiñán S, Cruz-Perera C, Díaz-Martín L, González-Rinne F, González-Delgado A, Torres A, Gaspari F, Hernández-Marrero D, Ortiz A, Porrini E, Luis-Lima S.
    Int J Mol Sci; 2024 May 05; 25(9):. PubMed ID: 38732256
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.